Source: Annual Congress 2010 - COPD and asthma: models and human studies
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Gagliardo, P. Chanez, M. Profita, G. D. Albano, A. M. Montalbano, F. Pompeo, A. Bonanno, A. M. Merendino, M. Gjomarkaj (Palermo, Italy; Marseille, France). Differential involvement of IκB kinases α and β in asthma and COPD. Eur Respir J 2010; 36: Suppl. 54, 2001

Member's Comments

No comment yet.

Related content which might interest you: Role of genetic polymorphism in TNF α and TGF β gene in Polish patients with sarcoidosis Source: Annual Congress 2010 - Sarcoidosis: from the bench to the bedside Year: 2010 Role of PPARγ in pulmonary hypertension and the relationship between PPARγ and PKC Source: Annual Congress 2009 - Pathobiology of pulmonary vascular diseases Year: 2009 TGF-β 1 suppresses IRF-1 expression in pulmonary fibroblasts and modulates its induction by IFN α and IFN γ Source: Annual Congress 2011 - Lung cell injury and repair Year: 2011 Tumor necrosis factor-α (TNF- α) gene polymorphysm in work-related chronic bronchitis prognosis Source: Annual Congress 2012 - COPD beyond tobacco Year: 2012 The in-vitro pharmacology of PF-3429281 – A novel inhaled dual antimuscarinic/β2 adrenoceptor agonist Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators Year: 2010 Interferon gamma release assays in screening for tuberculosis – Can we use them in patients with sarcoidosis? Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders Year: 2011 Airway resistances: Raw, sRaw, sReff – Which is the best determinant of airway function? Source: Annual Congress 2010 - Lung function from infancy to adulthood Year: 2010 Role of -511C>T/+3953C>T haplotypes of IL1B gene as risk factors of COPD Source: Annual Congress 2012 - Recent progress in mechanisms and diagnostics of COPD and asthma Year: 2012 Sensitivity and specificity of airway hyperreactivity (AHR) based on methacholine challenge (MCH) tests – Comparison of sGeff with FEV1 and MEF50 as target parameter Source: Annual Congress 2012 - Bronchial challenge as a biomarker of respiratory disease Year: 2012 Expression of human β defensin-1 is related to progressive lung function impairment in COPD Source: Annual Congress 2009 - Pathology and immunology of COPD Year: 2009 The in vitro biology of PF-00610355 – a novel β2 adrenoceptor agonist with a long duration of action Source: Annual Congress 2009 - Models of chronic airways disease and therapy Year: 2009 α-b crystallin – a marker for inflammation in COPD patients Source: Annual Congress 2009 - Airway inflammation and host defence Year: 2009 Targeting the IL-1β – IL-17A inflammatory axis for the treatment of viral-induced exacerbations of COPD Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD Year: 2012 Differential regulation of TNF-α and TGF- β production by PAI-1 in lung cancer and endothelial cells Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010 The role of E-cadherin polymorphisms in the annual FEV1 decline in asthma Source: Annual Congress 2009 - Genetics of lung diseases Year: 2009 BAMBI – A TGF-β pseudoreceptor with possible functional involvement in COPD and NTHI infection Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease Year: 2011 IL1RL1 polymorphisms are associated with the level of soluble IL1RL1 and asthma development in children Source: Annual Congress 2009 - Asthma genetics: from genome wide to single nucleotide polymorphisms Year: 2009 Adrenomedullin – a protective factor in asthma? Source: Annual Congress 2009 - Animal models of airways inflammation Year: 2009 Clinical decision making in alpha1 antitrypsin deficiency emphysema – Methodologies to determine individual rates of FEV1 decline Source: Annual Congress 2010 - Novel biomarkers and old parameters in approaching pulmonary diseases Year: 2010 The in-vitro pharmacology of PF-4522971 – A novel inhaled Muscarinic M3 Antagonist Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators Year: 2010